19-50407184-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_002691.4(POLD1):​c.1686+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000716 in 1,592,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000071 ( 0 hom. )

Consequence

POLD1
NM_002691.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.19

Publications

0 publications found
Variant links:
Genes affected
POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]
POLD1 Gene-Disease associations (from GenCC):
  • POLD1-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 10
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • mandibular hypoplasia-deafness-progeroid syndrome
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, Orphanet, G2P
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 120
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • non-severe combined immunodeficiency due to polymerase delta deficiency
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 19-50407184-C-T is Benign according to our data. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50407184-C-T is described in CliVar as Likely_benign. Clinvar id is 220860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POLD1NM_002691.4 linkc.1686+10C>T intron_variant Intron 13 of 26 ENST00000440232.7 NP_002682.2 P28340A0A024R4F4Q59FA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLD1ENST00000440232.7 linkc.1686+10C>T intron_variant Intron 13 of 26 1 NM_002691.4 ENSP00000406046.1 P28340

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152158
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000332
AC:
8
AN:
241148
AF XY:
0.0000306
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000549
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000555
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000715
AC:
103
AN:
1440750
Hom.:
0
Cov.:
33
AF XY:
0.0000673
AC XY:
48
AN XY:
713104
show subpopulations
African (AFR)
AF:
0.0000302
AC:
1
AN:
33074
American (AMR)
AF:
0.00
AC:
0
AN:
43818
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25440
East Asian (EAS)
AF:
0.0000766
AC:
3
AN:
39168
South Asian (SAS)
AF:
0.0000352
AC:
3
AN:
85268
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52008
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5704
European-Non Finnish (NFE)
AF:
0.0000830
AC:
91
AN:
1096948
Other (OTH)
AF:
0.0000843
AC:
5
AN:
59322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152158
Hom.:
0
Cov.:
30
AF XY:
0.0000673
AC XY:
5
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41436
American (AMR)
AF:
0.0000655
AC:
1
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.543
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000102
Hom.:
0
Bravo
AF:
0.0000756

ClinVar

Significance: Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 30, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 12, 2019
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 05, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: POLD1 c.1686+10C>T alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 3.3e-05 in 241148 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1686+10C>T in individuals affected with Colorectal Cancer and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -

Colorectal cancer, susceptibility to, 10 Benign:2
Feb 07, 2025
Myriad Genetics, Inc.
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Carcinoma of colon Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The POLD1 c.1686+10C>T variant was not identified in the literature. The variant was identified dbSNP (rs372652150) as “with likely benign allele” and ClinVar (classified as likely benign by Invitae and GeneDx). The variant was identified in control databases in 11 of 267,230 chromosomes at a frequency of 0.00004 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 2 of 23,800 chromosomes (freq: 0.00008), European in 7 of 123,466 chromosomes (freq: 0.00006), East Asian in 1 of 18,704 chromosomes (freq: 0.00005), and South Asian in 1 of 29,814 chromosomes (freq: 0.00003). The variant was not observed in the Other, Latino, Ashkenazi Jewish, or Finnish, populations. The variant occurs at a non-highly conserved nucleotide outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.39
DANN
Benign
0.85
PhyloP100
-3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372652150; hg19: chr19-50910441; COSMIC: COSV70954692; COSMIC: COSV70954692; API